AFTER THE EARTHQUAKES WITH EPICENTER IN KAHRAMANMARAŞ ON FEBRUARY 6, 2023; CRUSH SYNDROME

One of the vital problems after earthquakes that caused many deaths and injuries is crush syndrome due to traumatic muscle damage. After the two earthquakes of 7.7 and 7.6 magnitude affecting 11 provinces with the epicentre in Kahramanmaraş on 6 February 2023, 319 patients over the age of 18 were admitted to Sivas Cumhuriyet University Research and Practice Hospital between 6-14 February. 87 of 319 patients received inpatient follow-up and treatment. The age, gender, duration of stay in the rubble, province of residence, operation performed, duration of hospital stay, amount of fluid given in the first 24 hours, amount of urine output in the first 24 hours, body trauma sites, some laboratory parameters at the time of admission and during follow-up were retrospectively evaluated from the hospital records of all 43 patients diagnosed with crush syndrome among the inpatients between 6-28 February. The age of the patients was 39±19.6 years, duration of stay under the cave-in (hours) 22.74±36.32, duration of hospitalization (days) 7.26±5.42, amount of fluid given in the first 24 hours (ml) 4954.18±3142, amount of urine output in the first 24 hours (ml) 2646.42±2262.65, admission creatinine (mg/dl) 1.59±2.25, admission creatine kinase (CK) (U/L) 11716.37±18520. 44.2% of the patients were female, 72.1% came from Kahramanmaraş province, 46.5% underwent surgical intervention, 67.4% had an admission CK above 1000 u/l, 14% received hemodialysis treatment, 46.5% had a duration of hospitalization shorter than 7 days to reach the CK reference range and 51.2% had a duration of hospitalization longer than 21 days. The effect of other parameters on the duration of hospitalization and the time to reach the reference range of CK and correlation with laboratory parameters were analysed. As a result, it is thought that the parameters affecting the time to reach the CK reference range and the duration of hospitalization can be used to calculate and reduce the duration of hospitalization in prospective crush syndrome cases.